Annual Report

Foghorn Therapeutics Inc. Filed 2024-03-07 Acc 0001628280-24-009539

Documents 1

2025-03-06 10-K Annual Report
2024-03-12 4 Chief Strategy/Bus Ops Officer sold 11,000 shares at $6.56 ($72,134)
2024-03-07 8-K Results of operations · Regulation FD disclosure
2024-03-07 10-K Annual Report
2023-03-09 10-K Annual Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading fhtx-20231231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…